Skip to search formSkip to main contentSkip to account menu

Linomide

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2000
Highly Cited
2000
Objective: To determine the safety and efficacy of roquinimex (linomide) in the management of relapsing-remitting and secondary… 
1999
1999
Since prostate cancer (PC) development involves a combination of genetic predisposition and promotional mechanisms, especially… 
Highly Cited
1998
Highly Cited
1998
Oral linomide, (quinoline-3-carboxamide), has been shown to prevent autoimmune insulitis, islet destruction, and diabetes in NOD… 
Highly Cited
1997
Highly Cited
1997
Linomide is a p.o. active antiangiogenic agent that has been demonstrated to be effective in suppressing the in vivo growth of… 
Highly Cited
1996
Highly Cited
1996
Linomide (quinoline-3-carboxamide) is a synthetic immunomodulator that increases the natural killer cell activity. We previously… 
1995
1995
Linomide, a quinoline‐3‐carboxamide, has growth‐inhibitory effects against a series of Dunning R‐3327 rat prostatic cancers in… 
Highly Cited
1993
Highly Cited
1993
Linomide is a synthetic immunomodulator that enhances natural killer cell activity and significantly activates several… 
Highly Cited
1993
Highly Cited
1993
Linomide (LS‐2616, quinoline‐3‐carboxamide) is a synthetic immunomodulator that stimulates natural killer cell activity and… 
Highly Cited
1993
Highly Cited
1993
Intravenous injections of 50 μ.g Staphylococcus aureus enterotoxin B (SEB) or bacterial lipopolysaccharide (LPS) are lethal… 
Highly Cited
1992
Highly Cited
1992
Immunostimulatory therapy is at present considered after autologous bone marrow transplantation (ABMT) in order to mimic the…